Related Experiment Videos
A new quantitative HIV load assay based on plasma virion reverse transcriptase activity for the different types,
Joséphine Braun1, Jean-Christophe Plantier, Marie-France Hellot
1Laboratoire de Virologie, Biostatistique, Centre Hospitalier Charles Nicolle, 1 rue de Germont, 76031 Rouen cedex, France.
AIDS (London, England)
|January 31, 2003
Summary
A new assay measuring plasma reverse transcriptase (RT) activity offers a simple, affordable alternative for HIV viral load monitoring. This method is particularly valuable for resource-limited settings, providing reliable HIV diagnosis and treatment monitoring.
Area of Science:
- Virology
- Immunology
- Public Health
Background:
- Plasma viral load monitoring is crucial for HIV care in developed nations.
- Access to viral load assays in developing countries is limited by cost and technical challenges.
Purpose of the Study:
- To evaluate a novel, simple quantitative assay for plasma HIV reverse transcriptase (RT) activity.
- To compare RT activity-based and RNA-based quantification across diverse HIV-1 subtypes (group M, group O) and HIV-2.
Main Methods:
- The RT assay quantifies virion-protected RT activity using an enzyme immunoassay.
- Plasma viral load was assessed by both RT activity and RNA copies in 322 samples from 236 HIV-1 group M patients and 49 patients with HIV-1 group O or HIV-2.
Main Results:
- RT activity and RNA copies were detected in 70% of samples.
- RT activity and RNA copy measurements showed strong correlation across different HIV subtypes and groups (P < 0.0001).
- Patient follow-up revealed consistent viral load patterns between the two assay methods.
Conclusions:
- The plasma RT activity assay is a cost-effective and dependable method for HIV viral load determination.
- This assay holds significant potential for HIV diagnosis and treatment monitoring in developing countries.